Pharmacokinetically Based Mapping Device for Chemical Space Navigation-Reference-Cited by-同舟云学术

Pharmacokinetically Based Mapping Device for Chemical Space Navigation

Published:2002-04-18 Issue:4 Volume:4 Page:258-266
ISSN:1520-4766
Container-title:Journal of Combinatorial Chemistry
language:en
Short-container-title:J. Comb. Chem.

Author:

Oprea Tudor I.¹,Zamora Ismael¹,Ungell Anna-Lena¹

Affiliation:

1. EST Chemical Computing, AstraZeneca R&D Mölndal, S-43183 Mölndal, Sweden, and DMPK & Bioanalytical Chemistry, AstraZeneca R&D Mölndal, S-43183 Mölndal, Sweden

Publisher

American Chemical Society (ACS)

Subject

General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/cc010093w

Reference55 articles.

1. Drug-like properties and the causes of poor solubility and poor permeability

2. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

3. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence for Drug Discovery: Are We There Yet?;Annual Review of Pharmacology and Toxicology;2024-01-23

2. Chemical space and molecular descriptors for QSAR studies;Cheminformatics, QSAR and Machine Learning Applications for Novel Drug Development;2023

3. Docking and 2D-Structure-activity Relationship and ADMET Studies of Acetylcholinesterase Inhibitors;PHYS CHEM RES;2022

4. Analysis of the uncharted, druglike property space by self-organizing maps;Molecular Diversity;2021-10-28

5. Modeling approaches for reducing safety-related attrition in drug discovery and development: a review on myelotoxicity, immunotoxicity, cardiovascular toxicity, and liver toxicity;Expert Opinion on Drug Discovery;2021-06-28